Photodynamic inactivation of normal and antifungal resistant Candida species

Photodiagnosis and Photodynamic Therapy

Volumn 7, Issue 2, 2010, Pages 98-105

  Mang, T S ^a   Mikulski, L ^a   Hall, R E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

AIDS; Antifungal resistance; Candida; PDT

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; COLONY FORMING UNIT S; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; HUMAN; LASER; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURVIVAL; ADULT; AIDS RELATED COMPLEX; CANDIDIASIS; CELL CULTURE; CLASSIFICATION; COMPLICATION; DISEASE PREDISPOSITION; MICROBIOLOGY; RADIATION RESPONSE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDA; CANDIDIASIS; CELLS, CULTURED; DIHEMATOPORPHYRIN ETHER; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, FUNGAL; HUMANS; PHOTOSENSITIZING AGENTS;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS;

EID: 77952668740     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2010.03.001     Document Type: Article

References (26)

1. Odds F.C., Abbott A.B., Stiller R.L., Shcoler H.J., Polak A., and Stevens D.A. Analysis of Candida albicans pheotypes from different geographical and anatomical sources. J Cliin Microbiol 18 (1983) 849-857
2. Odds F.C., Kibbler C.C., Walker E., Bhamra A., Prentice H.G., and Noone P. Carriage of Candida species and C albicans biotypes in patients undergoing chemotherapy of bone marrow transplantation for heaematological disease. J Clin Pathol 42 (1989) 1259-1266
3. Pires F.R., Santos E.B.D., Bonan P.R.F., De Almeida O.P., and Lopes M.A. Denture stomatitis and salivary Candida in Brazilian edentulous patients. J Oral Rehabil 29 (2002) 1115-1119
4. Crockett D.N., O'Grady J.F., and Reade P.C. Candida species and Candida albicans morphytes in erythematous candidiasis. Oral Surg Oral Med Oral Pathol 73 (1992) 559
5. Pankhurst C. Oropharyngeal candidiasis. Clin Evid 4 (2001) 761-772
6. Walsh T.J., Gonzalez C.E., Piscitelli S., et al. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and Esophageal candidiasis. J Clin Microbiol 28 (2000) 2369-2373
7. Wilson B.D., Mang T.S., Cooper M., and Stoll H. Use of photodynamic therapy for the treatment of extensive basal cell carcinomas. Facial Plast Surg 6 (1989) 185-189
8. Wilson B.D., Mang T.S., Stoll H., Jones C., Cooper M., and Dougherty T.J. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 128 (1992) 1597-1601
9. Weishaupt K.R., Gomer C.J., and Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 36 (1976) 2326-2329
10. Dougherty T.J., and Marcus S.L. Photodynamic therapy: review. Eur J Cancer 28A (1992) 1734-1742
11. Chavarria A.P., and Clark J.H. The reaction of pathogenic fungi to ultraviolet light. Am J Hyg 4 (1924) 639-649
12. Dickey R.F. Investigative studies in fungicidal powers of photodynamic action. Invest Dermatol 39 (1962) 7-19
13. Bliss J.M., Bigelow C.E., Foster T.H., and Haidaris C.G. Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob Agents Chemother 48 (2004) 2000-2006
14. Teichert M.C., Jones B.A., Usacheva M.N., and Biel M.A. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 (2002) 155-160
15. Rosello Y.C., Foster T.H., Perez-Nazario N., Mitra S., and Haidaris C.G. Sensitivity of Candia albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob Agents Chemother 49 (2005) 4288-4295
16. Chadbourne K., Mikulski L., and Mang T.S. Photodynamic therapy of oral microbes. Abstracts 35th annual Meeting of the AADR. Orlando, FL (2006)
17. Thorsrud K.J., Mang T.S., and Hall R.E. In vitro photodynamic treatment of S. Mutans with m-THPC. Abstract 90th annual meeting of the AAOMS Seattle Wash (2008)
18. Powderly W.G., Mayer K.H., and Perfect J.R. Diagnosis and treatment of oropharyngela candiddiasis in patients infected with HIV: a critical reassessment. AIDS Res Hum Retroviruses 15 (1999) 1405-1412
19. Wai So C., Tsang P.W.K., Lo P.C., Seneviratne C.J., Samaranayake L.P., and Fong W.P. Photodynamic inactivation of Candida albicans by BAM-SiPc. Mycoses (2009) March early view online 1-6
20. Dovigo L.N., Pavarina A.C., deOliveira Mima E.G., Giampaolo E.T., Vergani C.E., and Bagnato V.S. Fungicidal effect of photodynamic therapy against fluconazole resistant Candida albicans and Candida glabrata. Mycoses (2009) November early view online 1-8
21. Barchiesi F., Maracci M., Radi B., et al. Point prevelance, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. J Antimicrob Chemother 50 (2002) 999-1002
22. Nolte F.S., Parkinson T., Falconer D.J., et al. Isolation and characterization of fluconazole and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 44 (1997) 196-199
23. Nevill B.W., Damm D.D., Allen C.M., and Bouquot J.E. Oral and maxillofacial pathology. 2nd ed. (2002), W.B. Saunders, Philedelphia
24. Davies r, Bedi R., and Scully C. Oral health care for patients with special needs. Br Med J 21 (2000) 19-26
25. Campisi G., Pizzo G., Milici M.E., Mancuso S., and Margiotta V. Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects. Oral Surg Oral Med Oral Pathol 93 (2002) 281-286
26. Trofa D., Gácser A., and Nosanchuk J.D. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 21 (2008) 606-625